期刊文献+

洛美沙星和环丙沙星对小鼠肝肾的毒性作用 被引量:5

THE LIVER AND RENAL TOXICITY OF LOMEFLOXACIN AND CIPROFLOXACIN IN MICE
下载PDF
导出
摘要 目的:研究洛美沙星(LFX)和环丙沙星(CPLX)对小鼠肝肾的毒性作用。方法:分别单次ipLFX和CPLX各0.375,0.75和1.5mg/10g体重,所有小鼠15d后处死。结果:部分肝脏及肾脏与周围组织粘连;CPLX(1.5mg/10g)组第3蛋白电泳带含量比对照组增加48.1%(P<0.05);肝重/10g体重及肝功能无明显变化;光镜下,除LFX(0.375mg/10g)组外,各组肝细胞有不同程度变性和坏死;LFX(1.5mg/10g)组1例肾脏为慢性间质性肾炎改变。结论:LFX和CPLX对小鼠肝脏有潜在的毒性作用,且无明显的剂量依赖性。 OBJECTIVE:To study the liver and renal toxic reactions of lomefloxacin and ciprofloxacin in mice.METHODS:A single dose of 0.375,0.75 and 1.5 mg/10 g body weight of lomefloxacin and ciprofloxacin were given by intraperitoneally injection to mice. After 15 days of administration all animals were killed by decapitation.RESULTS:The liver and kidney of some animals in treated groups were adhered to the surrounding tissues.The third serum fractions in ciprofloxacin (1.5 mg/10 g body weight)treated mice increased 48.1%( P <0.05)in comparison with that of saline treated mice.No significant changes were observed in the ratio of liver/10 g body weight and liver function.Hepatocyte degeneration and necrosis of various degrees could be seen by light microscopy in lomefloxacin treated group. One case of chronic interstitial nephritis was observed in lomefloxacin treated group.CONCLUSION:Lomefloxacin and ciprofloxacin have potential toxicities to liver and kidney in mice but it seems unlikely to be dose dependence.Therefore,these drugs should be used with caution in patients with liver or renal dysfunction.
出处 《中国新药杂志》 CAS CSCD 1999年第1期18-20,共3页 Chinese Journal of New Drugs
关键词 洛美沙星 环丙沙 毒性作用 药理 Lomefloxacin Ciprofloxacin Toxicity
  • 相关文献

参考文献1

  • 1宋祖元 杨体模 等.环丙沙星、氧氟沙星、依诺沙星对小鼠单次ip产生肝损伤作用程度比较[J].四川生理科学杂志,1995,17(2):76-76.

同被引文献29

  • 1刘广余,李苏芹,丁梅芳,邵志高.国产洛美沙星的体内抗菌作用研究[J].中国药理学通报,1995,11(2):151-154. 被引量:2
  • 2徐淑云.药理实验方法学(第二版)[M].北京:人民卫生出版社,1991.707-708.
  • 3邵剑峰.环丙沙星致幻视2例报告[J].实用老年医学,1995,9(5):204-204.
  • 4卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 5林赴田.洛米沙星药理及临床[J].新药与市场,1990,(4):8.
  • 6中岛光好,植松俊彦,淹田祥会,et al.Fleroxacinの第一相临床试验Ⅰ[J].Chemotherapg,1990,(S-2):280.
  • 7[3]KVSAJMA H,Ishikawa N,Machida,et al.Pharmacokinetics of a new Quinolone,AM-833,InMics,Rates,Rabbits,Dogs and Monkeys[J].Antimicrob Ag Chemother,1986,30(2):304.
  • 8[4]Nakashima M,Kanamaru M,Uematsu T,et al.Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers[J].J Antimicrob Chem other,1988,22(Suppl D):133.
  • 9[5]Fernandes P B.Mode of action,and in vitro and in vivo activities of the fluoroquinolones[J].J Clin Pharmacol,1988,28:156-158.
  • 10丁晓萍.环丙沙星引起严重神经精神症状 1例[J].医药导报,1997,16(3):140.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部